Has Priya Gor, MD received payments from drug or device companies?

Yes. Drug and device makers reported $344 in general payments to Priya Gor, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Priya Gor, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Priya Gor, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Priya Gor, MD

Hematology & Oncology · Cherry Hill, NJNPI 1710915269

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Pfizer at 34.5% of the total. 2025 is the largest year on record at $133, more than ten times the $12 reported in 2021. That places this record below the midpoint for hematology & oncology clinicians in NJ, where the typical reported total is $2,686.

$344in general payments, 2019–2025

Across 11 payments — averaging $31.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$119
Daiichi Sankyo Inc.$47
Stemline Therapeutics Inc.$42
GSK$40
E.r. Squibb & Sons, L.L.C.$28
Gilead$28
plus $42 from 2 others

$10,000in research payments, 2019–2025

Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$10K

What the payments were for

Food & beverage$33397%
Education$123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	1	$119
Daiichi Sankyo Inc.	2	$47
Stemline Therapeutics Inc.	1	$42
GSK	2	$40
E.r. Squibb & Sons, L.L.C.	1	$28
Gilead	2	$28
Bayer	1	$23
AbbVie	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IBRANCE$119

How this compares

$344 in reported general payments places this provider in the 20th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$2,268,435

Medicare patients

515

Services billed

93,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
KisqaliRibociclib Succinate	32	$550,122
VerzenioAbemaciclib	27	$393,716
TruqapCapivasertib	12	$280,460
Anastrozole	415	$11,564
Exemestane	82	$10,634
Letrozole	65	$1,817
Tamoxifen Citrate	46	$1,313
Alendronate Sodium	63	$512
Oxybutynin Chloride	12	$417
Lidocaine-PrilocaineLidocaine/Prilocaine	27	$394
Gabapentin	16	$377
Prochlorperazine Maleate	27	$269
Ondansetron OdtOndansetron	17	$226
Duloxetine Hcl	11	$188
Ondansetron Hcl	12	$66

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Cherry Hill

Stephen ZradaCherry Hill$34K
Robert SpiegelWestfield$864K
Amit PatelJersey City$770K
Joshua StraussSpringfield$739K
Charles FarberMorristown$609K
Michael ScolaMorristown$506K
Eshan PatelSomerville$420K
Arturo Loaiza-BonillaPennington$406K
Ashish ShahSpringfield$394K
Carl HenningsonManasquan$349K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →